Recombinase-Dependent Mouse Lines for Chemogenetic Activation of Genetically Defined Cell Types

Cell Reports

Volumn 15, Issue 11, 2016, Pages 2563-2573

  Sciolino, Natale R ^a   Plummer, Nicholas W ^a   Chen, Yu Wei ^a   Alexander, Georgia M ^a   Robertson, Sabrina D ^b   Dudek, Serena M ^a   McElligott, Zoe A ^c   Jensen, Patricia ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; CRE RECOMBINASE; GLIAL FIBRILLARY ACIDIC PROTEIN; HYBRID PROTEIN; MUSCARINIC M3 RECEPTOR; UNCLASSIFIED DRUG; CLOZAPINE; DESIGNER DRUG; INTEGRASE;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CELL BODY; CONTROLLED STUDY; DENDRITE; EMBRYO; GENE EXPRESSION; GLIA; HIPPOCAMPAL CA3 REGION; HYPOTHERMIA; LOCOMOTION; LOCUS CERULEUS; MOUSE; NONHUMAN; NORADRENERGIC NERVE CELL; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; COMPLICATION; DRUG EFFECTS; GAMMA RHYTHM; GENETIC PROCEDURES; GENETIC RECOMBINATION; GENETICS; HIPPOCAMPUS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ALLELES; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CLOZAPINE; DENDRITES; DESIGNER DRUGS; GAMMA RHYTHM; GENETIC TECHNIQUES; HIPPOCAMPUS; HUMANS; HYPOTHERMIA; INTEGRASES; LOCOMOTION; MICE; NEUROGLIA; RECEPTOR, MUSCARINIC M3; RECOMBINATION, GENETIC;

EID: 84974703325     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.05.034     Document Type: Article

References (31)

1. Agulhon C., Boyt K.M., Xie A.X., Friocourt F., Roth B.L., McCarthy K.D. Modulation of the autonomic nervous system and behaviour by acute glial cell Gq protein-coupled receptor activation in vivo. J. Physiol. 2013, 591:5599-5609.
2. Alexander G.M., Rogan S.C., Abbas A.I., Armbruster B.N., Pei Y., Allen J.A., Nonneman R.J., Hartmann J., Moy S.S., Nicolelis M.A., et al. Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 2009, 63:27-39.
3. Anastassiadis K., Fu J., Patsch C., Hu S., Weidlich S., Duerschke K., Buchholz F., Edenhofer F., Stewart A.F. Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis. Model. Mech. 2009, 2:508-515.
4. Armbruster B.N., Li X., Pausch M.H., Herlitze S., Roth B.L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. USA 2007, 104:5163-5168.
5. Atasoy D., Aponte Y., Su H.H., Sternson S.M. A FLEX switch targets Channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping. J. Neurosci. 2008, 28:7025-7030.
6. Bender D., Holschbach M., Stöcklin G. Synthesis of n.c.a. carbon-11 labelled clozapine and its major metabolite clozapine-N-oxide and comparison of their biodistribution in mice. Nucl. Med. Biol. 1994, 21:921-925.
7. Carter M.E., Yizhar O., Chikahisa S., Nguyen H., Adamantidis A., Nishino S., Deisseroth K., de Lecea L. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat. Neurosci. 2010, 13:1526-1533.
8. Casper K.B., Jones K., McCarthy K.D. Characterization of astrocyte-specific conditional knockouts. Genesis 2007, 45:292-299.
9. de Oliveira R.B., Howlett M.C., Gravina F.S., Imtiaz M.S., Callister R.J., Brichta A.M., van Helden D.F. Pacemaker currents in mouse locus coeruleus neurons. Neuroscience 2010, 170:166-177.
10. Friedrich G., Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 1991, 5:1513-1523.
11. George S.H., Gertsenstein M., Vintersten K., Korets-Smith E., Murphy J., Stevens M.E., Haigh J.J., Nagy A. Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc. Natl. Acad. Sci. USA 2007, 104:4455-4460.
12. Kimmel R.A., Turnbull D.H., Blanquet V., Wurst W., Loomis C.A., Joyner A.L. Two lineage boundaries coordinate vertebrate apical ectodermal ridge formation. Genes Dev. 2000, 14:1377-1389.
13. Lewandoski M., Meyers E.N., Martin G.R. Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb. Symp. Quant. Biol. 1997, 62:159-168.
14. McCall J.G., Al-Hasani R., Siuda E.R., Hong D.Y., Norris A.J., Ford C.P., Bruchas M.R. CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety. Neuron 2015, 87:605-620.
15. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
16. Paxinos G., Franks K.B.J. The mouse brain in sterotaxic coordinates 2013, Academic Press, San Diego.
17. Plummer N.W., Evsyukova I.Y., Robertson S.D., de Marchena J., Tucker C.J., Jensen P. Expanding the power of recombinase-based labeling to uncover cellular diversity. Development 2015, 142:4385-4393.
18. Raymond C.S., Soriano P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2007, 2:e162.
19. Robertson S.D., Plummer N.W., de Marchena J., Jensen P. Developmental origins of central norepinephrine neuron diversity. Nat. Neurosci. 2013, 16:1016-1023.
20. Rodríguez C.I., Buchholz F., Galloway J., Sequerra R., Kasper J., Ayala R., Stewart A.F., Dymecki S.M. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 2000, 25:139-140.
21. Sauer B. Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 1993, 225:890-900.
22. Schnütgen F., Doerflinger N., Calléja C., Wendling O., Chambon P., Ghyselinck N.B. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat. Biotechnol. 2003, 21:562-565.
23. Sciolino N.R., Smith J.M., Stranahan A.M., Freeman K.G., Edwards G.L., Weinshenker D., Holmes P.V. Galanin mediates features of neural and behavioral stress resilience afforded by exercise. Neuropharmacology 2015, 89:255-264.
24. Sonner J.M., Cascio M., Xing Y., Fanselow M.S., Kralic J.E., Morrow A.L., Korpi E.R., Hardy S., Sloat B., Eger E.I., Homanics G.E. Alpha 1 subunit-containing GABA type A receptors in forebrain contribute to the effect of inhaled anesthetics on conditioned fear. Mol. Pharmacol. 2005, 68:61-68.
25. Teissier A., Chemiakine A., Inbar B., Bagchi S., Ray R.S., Palmiter R.D., Dymecki S.M., Moore H., Ansorge M.S. Activity of Raphé Serotonergic Neurons Controls Emotional Behaviors. Cell Rep. 2015, 13:1965-1976.
26. Tsien J.Z., Chen D.F., Gerber D., Tom C., Mercer E.H., Anderson D.J., Mayford M., Kandel E.R., Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 1996, 87:1317-1326.
27. Urban D.J., Roth B.L. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu. Rev. Pharmacol. Toxicol. 2015, 55:399-417.
28. Williams J.T., North R.A., Shefner S.A., Nishi S., Egan T.M. Membrane properties of rat locus coeruleus neurones. Neuroscience 1984, 13:137-156.
29. Xia Z., Hufeisen S.J., Gray J.A., Roth B.L. The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro. Neuroscience 2003, 122:907-920.
30. Zhu H., Roth B.L. DREADD: a chemogenetic GPCR signaling platform. Int. J. Neuropsychopharmacol. 2014, 18:pyu007.
31. Zufferey R., Donello J.E., Trono D., Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 1999, 73:2886-2892.